Skip to main content
logo
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
115.96
+6.36 (5.80%)
At close: Aug 14, 2026, 4:00 PM EDT
117.00
+1.04 (0.90%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Dianthus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.92.046.242.836.421.48
Revenue Growth
-60.77%-67.35%120.63%-55.96%334.76%-
Gross Profit
1.92.046.242.836.421.48
Selling, General & Admin
44.1334.3324.9918.166.741.96
Research & Development
175.62145.6483.1132.8429.3812.61
Operating Expenses
219.75179.97108.15136.1214.56
Operating Income
-217.84-177.93-101.86-48.17-29.71-13.09
Interest & Investment Income
16.699.9611.354.761.150
Currency Exchange Gain (Loss)
-0.03-0.06-0.06-0.090.14-0.03
Other Non Operating Income (Expenses)
-1.39-0.97-0.55-0.06-0.05-
EBT Excluding Unusual Items
-202.57-169.01-91.14-43.56-28.48-13.11
Gain (Loss) on Sale of Investments
10.326.676.17---
Pretax Income
-192.25-162.34-84.97-43.56-28.48-13.11
Net Income
-192.25-162.34-84.97-43.56-28.48-13.11
Net Income to Common
-192.25-162.34-84.97-43.56-28.48-13.11
Net Income Growth
------
Shares Outstanding (Basic)
473933514
Shares Outstanding (Diluted)
473933514
Shares Change
32.34%15.92%546.44%489.48%-78.17%-
EPS (Basic)
-4.11-4.20-2.55-8.45-32.57-3.27
EPS (Diluted)
-4.11-4.20-2.55-8.45-32.57-3.27
EPS Growth
------
Free Cash Flow
-155.71-129.27-78.29-36.97-29.21-9.94
Free Cash Flow Per Share
-3.33-3.35-2.35-7.17-33.41-2.48
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-11441.39%-8739.34%-1633.75%-1704.67%-462.91%-886.59%
Profit Margin
-10096.95%-7973.33%-1362.78%-1541.22%-443.76%-888.14%
Free Cash Flow Margin
-8177.99%-6349.36%-1255.57%-1308.24%-455.18%-673.24%
EBITDA
-217.72-177.82-101.77-48.11-29.68-
D&A For EBITDA
0.120.110.10.070.03-
EBIT
-217.84-177.93-101.86-48.17-29.71-13.09
Revenue as Reported
2.042.046.242.83--
SEC Filings: 10-K · 10-Q